Liver surgery in cirrhosis and portal hypertension

Por Hackl, Christina, Schlitt, Hans J, Renner, Philipp, Lang, Sven A
Publicado no World J Gastroenterol (2016)

Clinical Management of Acute Portal/Mesenteric Vein Thrombosis

Por Lang, Sven A., Loss, Martin, Wohlgemuth, Walter A., Schlitt, Hans J.
Publicado no Viszeralmedizin (2014)

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrosp...

Por Glockzin, Gabriel, Gerken, Michael, Lang, Sven A, Klinkhammer-Schalke, Monika, Piso, Pompiliu, Schlitt, Hans J
Publicado no BMC Cancer (2014)

Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry

Por Haimerl, Michael, Verloh, Niklas, Zeman, Florian, Fellner, Claudia, Nickel, Dominik, Lang, Sven A., Teufel, Andreas, Stroszczynski, Christian, Wiggermann, Philipp
Publicado no Sci Rep (2017)

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC...

Por Glockzin Gabriel, Rochon Justine, Arnold Dirk, Lang Sven A, Klebl Frank, Zeman Florian, Koller Michael, Schlitt Hans J, Piso Pompiliu
Publicado em 2013-02-01

ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

Por Moser, Christian, Lang, Sven A, Mori, Akira, Hellerbrand, Claus, Schlitt, Hans J, Geissler, Edward K, Fogler, William E, Stoeltzing, Oliver
Publicado em 2008

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC...

Por Glockzin, Gabriel, Rochon, Justine, Arnold, Dirk, Lang, Sven A, Klebl, Frank, Zeman, Florian, Koller, Michael, Schlitt, Hans J, Piso, Pompiliu
Publicado em 2013

ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resectio...

Por Joechle, Katharina, Moser, Christian, Ruemmele, Petra, Schmidt, Katharina M., Werner, Jens M., Geissler, Edward K., Schlitt, Hans J., Lang, Sven A.
Publicado no World J Surg Oncol (2017)

p16(INK4a) is a Prognostic Marker in Resected Ductal Pancreatic Cancer: An Analysis of p16(INK4a), p53, MDM2, an Rb

Por Gerdes, Berthold, Ramaswamy, Annette, Ziegler, Andreas, Lang, Sven A., Kersting, Michael, Baumann, Renate, Wild, Anja, Moll, Roland, Rothmund, Matthias, Bartsch, Detlef K.
Publicado em 2002

Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up

Por Dollinger, Marco, Müller-Wille, René, Zeman, Florian, Haimerl, Michael, Niessen, Christoph, Beyer, Lukas P., Lang, Sven A., Teufel, Andreas, Stroszczynski, Christian, Wiggermann, Philipp
Publicado no PLoS One (2015)

Correction: Irreversible Electroporation of Malignant Hepatic Tumors - Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up

Por Dollinger, Marco, Müller-Wille, René, Zeman, Florian, Haimerl, Michael, Niessen, Christoph, Beyer, Lukas P., Lang, Sven A., Teufel, Andreas, Stroszczynski, Christian, Wiggermann, Philipp
Publicado no PLoS One (2015)

Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition

Por Hackl, Christina, Lang, Sven A, Moser, Christian, Mori, Akira, Fichtner-Feigl, Stefan, Hellerbrand, Claus, Dietmeier, Wolfgang, Schlitt, Hans J, Geissler, Edward K, Stoeltzing, Oliver
Publicado em 2010

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))

Por GAUMANN, ANDREAS K.A., DREXLER, HANNES C.A., LANG, SVEN A., STOELTZING, OLIVER, DIERMEIER-DAUCHER, SIMONE, BUCHDUNGER, ELISABETH, WOOD, JEANETTE, BOLD, GUIDO, BREIER, GEORG
Publicado em 2014

Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models

Por Schmidt, Katharina M., Hellerbrand, Claus, Ruemmele, Petra, Michalski, Christoph W., Kong, Bo, Kroemer, Alexander, Hackl, Christina, Schlitt, Hans J., Geissler, Edward K., Lang, Sven A.
Publicado no Oncotarget (2017)

Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80(+)CD11b(high)Gr1(low) macrophages

Por Schiechl, Gabriela, Bauer, Bernhard, Fuss, Ivan, Lang, Sven A., Moser, Christian, Ruemmele, Petra, Rose-John, Stefan, Neurath, Markus F., Geissler, Edward K., Schlitt, Hans-Jürgen, Strober, Warren, Fichtner-Feigl, Stefan
Publicado em 2011

STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases

Por Moser, Christian, Ruemmele, Petra, Gehmert, Sebastian, Schenk, Hedwig, Kreutz, Marina P, Mycielska, Maria E, Hackl, Christina, Kroemer, Alexander, Schnitzbauer, Andreas A, Stoeltzing, Oliver, Schlitt, Hans J, Geissler, Edward K, Lang, Sven A
Publicado em 2012

New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells

Por Gottfried, Eva, Lang, Sven A., Renner, Kathrin, Bosserhoff, Anja, Gronwald, Wolfram, Rehli, Michael, Einhell, Sabine, Gedig, Isabel, Singer, Katrin, Seilbeck, Anton, Mackensen, Andreas, Grauer, Oliver, Hau, Peter, Dettmer, Katja, Andreesen, Reinhard, Oefner, Peter J., Kreutz, Marina
Publicado em 2013